Evaxion A (EVAX) Profit After Tax Growth (1y) (2021 - 2026)
Evaxion A (EVAX) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 66.06% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 17.05% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -290.15% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -129.68% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -632.44% |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 59.59% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | -10.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129.68% |
| Dec 31, 2025 | -63.08% |
| Sep 30, 2025 | 338.66% |
| Jun 30, 2025 | 22.06% |
| Mar 31, 2025 | -232.33% |
| Dec 31, 2024 | 19.77% |
| Sep 30, 2024 | 65.92% |
| Jun 30, 2024 | -9.06% |
| Mar 31, 2024 | 119.13% |
| Dec 31, 2023 | 34.18% |
| Sep 30, 2023 | 1.08% |
| Jun 30, 2023 | -19.19% |
| Mar 31, 2023 | 2.47% |
| Dec 31, 2022 | 17.90% |
| Sep 30, 2022 | -209.33% |
| Jun 30, 2022 | 30.08% |
| Mar 31, 2022 | -256.34% |
| Dec 31, 2021 | -96.06% |
| Sep 30, 2021 | 230.92% |
| Jun 30, 2021 | -87.34% |